Company Data
Aligos Therapeutics Inc.
Ticker
ALGS
Current Price
$5.5 -3%
Market Cap
$33.6M
Price Target
Refer to Report
Volume
76.0K
52wk Range
$3.76 - $46.8
Overview
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company’s pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.